ALSEA:BMVAlsea, S.A.B. de C.V. Analysis
Data as of 2026-06-21 - not real-time
Latest Price
Risk Level: Medium
Executive Summary
Alsea trades at MXN 46.86, sitting below its 20‑day (49.91), 50‑day (51.49) and 200‑day (54.05) moving averages, signaling a short‑term bearish bias. The RSI of 35 and a bearish MACD histogram reinforce downside pressure, while the price hovers just above the identified support at MXN 46.34. Despite the technical weakness, the company boasts a solid dividend yield of 2.13% with a modest payout ratio (~21%), strong operating cash flow (MXN 16.7 bn) and an attractive forward PE of 10.35, suggesting earnings growth ahead. However, the balance sheet is heavily leveraged, with a debt‑to‑equity ratio of 574% and net debt far exceeding cash reserves, raising concerns about financial flexibility. The DCF‑derived fair value of MXN 44.57 places the current price modestly above intrinsic estimates, hinting at slight overvaluation, yet analyst consensus targets around MXN 67 imply a sizable upside (~43%). The market sentiment is exuberant, reflected by a Fear & Greed Index of 91.46 (Extreme Greed), which may be inflating price expectations. Overall, Alsea presents a mixed picture: technical downside, strong cash generation, high leverage, and a dividend that remains sustainable under current cash flows.
Market Outlook
Short Term
< 1 yearKey Factors
- Price near technical support with bearish momentum
- Strong dividend yield and low payout ratio
- Elevated leverage increasing financial risk
Medium Term
1–3 yearsKey Factors
- Forward PE of 10.35 indicating earnings upside
- Analyst target price around MXN 67 suggesting 40% upside
- Robust operating cash flow supporting dividend and debt service
Long Term
> 3 yearsKey Factors
- Diversified brand portfolio across Latin America and Europe
- Sustainable dividend backed by cash flow generation
- Potential to deleverage over time improving balance‑sheet strength
Key Metrics & Analysis
Financial Health
Technical Analysis
Valuation
Risk Assessment
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.